Christopher Mutz, HEAD OF RARE DISEASE at ANI PHARMACEUTICALS INC (ANIP), sold 12,608 shares at $76.55 ($968K) on 2026-02-12, disclosed to the SEC on 2026-02-17.
Seasonal sale ($968k) by HEAD OF RARE DISEASE — this insider has traded ANIP in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $76.55 | 7,032 | $538K | 55.6% |
| 2 | $76.70 | 3,173 | $243K | 25.2% |
| 3 | $77.36 | 2,403 | $186K | 19.2% |
| Total | $76.74 avg | 12,608 | $968K | 100% |
| Filing → |
| ANIP | SELL | 2026-03-04 | $31K | — | Filing → |
| ANIP | SELL | 2026-02-23 | $415K | — | Filing → |
| ANIP | SELL | 2025-05-15 | $242K | — | Filing → |